Technology area: Chemistry & Materials
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zhejiang Huakang Pharmaceutical Co. Ltd. currently has 3 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 3 distinct examiners, which suggests that the company is dealing with multiple individual perspectives at the patent office. The prosecution is focused within a distinct art unit, indicating a concentrated technical field for these applications. This concentration in a single art unit may allow for a more consistent procedural approach despite the involvement of multiple examiners.
JOSEPH W DRODGE is the busiest examiner for the company, currently responsible for 1 pending office action. This represents a portion of the total workload, as the other cases are handled by different individuals. The presence of 1 pending office action with the busiest examiner highlights the distributed nature of the portfolio. With all cases situated in the Chemistry & Materials sector, the company's legal strategy must account for the specific examination standards of that field. Managing multiple pending office actions across various examiners requires careful coordination to ensure that arguments made in one case do not negatively impact the others.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DRODGE, JOSEPH W | 1 | 78.2% | +38.2% |
| LAU, JONATHAN S | 1 | 63.7% | -17.3% |
| MORENO, LARK JULIA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023836 | SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF | MORENO, LARK JULIA | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18655298 | METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE | DRODGE, JOSEPH W | — |
| Art Unit | Apps |
|---|---|
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18655298 | METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE | DRODGE, JOSEPH W | — | §112Other | Non-Final OA | — | Pending | May 05, 2024 |
| 18651633 | METHODS FOR PREPARING HIGH-PURITY ARABINOSE CRYSTALS | LAU, JONATHAN S | — | §112 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18023836 | SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF | MORENO, LARK JULIA | 1793 | §103§112 | Final Rejection | 34d | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial